Dexamethasone-induced inhibition of miR-132 via methylation promotes TGF-β-driven progression of pancreatic cancer

Glucocorticoids (GCs) such as dexamethasone (DEX) are administered as cancer co-treatment for palliative purposes due to their pro-apoptotic effects in lymphoid cancer and limited side effects associated with cancer growth and chemotherapy. However, there is emerging evidence that GCs induce therapy...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Int J Oncol
Main Authors: Abukiwan, Alia, Nwaeburu, Clifford C., Bauer, Nathalie, Zhao, Zhefu, Liu, Li, Gladkich, Jury, Gross, Wolfgang, Benner, Axel, Strobel, Oliver, Fellenberg, Jörg, Herr, Ingrid
פורמט: Artigo
שפה:Inglês
יצא לאור: D.A. Spandidos 2018
נושאים:
Articles
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6255064/
https://ncbi.nlm.nih.gov/pubmed/30387838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2018.4616
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים